| Primary information |
|---|
| sequence ID | Seq_903 |
| Peptide sequence | AVAIKAMAK |
| CancerPDF_ID | CancerPDF_ID11309, CancerPDF_ID12647, CancerPDF_ID12995, CancerPDF_ID13010, |
| PMID | 26992070,26992070,20974924,20974924 |
| Protein Name | Eukaryotic translation initiation factor 5A-1,Eukaryotic translation initiation factor 5A-1,Eukaryotic translation initiation factor 5A-1,Eukaryotic translation initiation factor 5A-1 |
| UniprotKB Entry Name | IF5A1_HUMAN,NCOA1_HUMAN,IF5A1_HUMAN,IF5A1_HUMAN |
| Fluid | Serum,Serum,Plasma,Plasma |
| M/Z | 901.54191,NA,902.55,918.545 |
| Charge | NA,NA,2,2 |
| Mass (in Da) | 902.5504016,918.542406,NA,NA |
| fdr | NA,NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS,LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA,NA,NA |
| Labelled/Label Free | Label Free,Label Free,Label Free,Label Free |
| FDR | FDR 1 %,FDR 1 %,NA,NA |
| CancerPDF_ID | CancerPDF_ID11309, CancerPDF_ID12647, CancerPDF_ID12995, CancerPDF_ID13010, |
| p-Value | NA,NA,NA,NA |
| Software | SEQUEST and Maxquant,"Maxquant,Proteome Discoverer",MASCOT and SEQUEST,MASCOT and SEQUEST |
| Length | 9,9,NA,NA |
| Cancer Type | Melanoma,Melanoma,"Multiple myeloma patients, Acute myeloid leukemia","Multiple myeloma patients, Acute myeloid leukemia" |
| Database | SwissProt Database,SwissProt Database,Uniprot database,Uniprot database |
| Modification | NA,NA,NA,Oxidation of methionine |
| Number of Patients | 8 cancer samples and 4 healthy samples,8 cancer samples and 4 healthy samples,NA,NA |
| Regulation | "Present in 4 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples.","Present in 4 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples.",NA,NA |
| Validation | na,NA,NA,NA |
| Sensitivity | NA,NA,NA,NA |
| Specificity | NA,NA,NA,NA |
| Accuracy | NA,NA,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 162034
|